← Eichor
Condition: Autoimmune Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Autoimmune Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Phase 2 · 1 location(s) · National and Kapodistrian University of Athens · NCT07584083PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07717281Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT06870045National Registry of IgG4-RD in China
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT03023371Foot Muscles Training in Sclerosis
NA · 1 location(s) · Inés Llamas-Ramos · NCT06665607A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06494228Dysphagia in Rheumatoid Arthritis
Phase N/A · 2 location(s) · Tanta University · NCT07401732Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Phase 1 · 5 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT06880081A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
EARLY_Phase 1 · 5 location(s) · Nanjing Legend Biotech Co. · NCT07095075Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
NA · 1 location(s) · Sun Yat-sen University · NCT06588764Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04833465Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · 7 location(s) · Oslo University Hospital · NCT06653634Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07242092RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
NA · 1 location(s) · Centro de Reabilitacao do Norte · NCT05461898Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · 76 location(s) · University of Leeds · NCT04102930LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
NA · 14 location(s) · Heinrich-Heine University, Duesseldorf · NCT05714930Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · 18 location(s) · Regeneron Pharmaceuticals · NCT06975787Systemic Lupus Erythematosus in Gullah Health
Phase N/A · 1 location(s) · Medical University of South Carolina · NCT00756769Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NA · 1 location(s) · University of Michigan · NCT07392879Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Phase N/A · 23 location(s) · Alexion Pharmaceuticals, Inc. · NCT06967480Skeletal Muscle Aging and Responsiveness in Aged People With MS
NA · 1 location(s) · Oklahoma Medical Research Foundation · NCT07500727tDCS in Post-Acute COVID-19 Patients With SARDs
NA · 1 location(s) · University of Sao Paulo · NCT04890483US Zamto-cel Autoimmune Diseases
Phase 1 · 1 location(s) · Miltenyi Biomedicine GmbH · NCT06708845Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
NA · 2 location(s) · T1D Exchange, United States · NCT06931275
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.